Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Embecta Corp. stock logo
EMBC
Embecta
$10.40
-4.5%
$12.90
$9.93
$32.00
$598.83M0.73412,285 shs488,927 shs
Paragon 28, Inc. stock logo
FNA
Paragon 28
$8.97
-7.0%
$10.92
$7.95
$19.72
$743.70M1.01527,318 shs403,565 shs
Nevro Corp. stock logo
NVRO
Nevro
$11.61
-7.2%
$14.05
$11.49
$34.86
$425.86M0.89474,770 shs346,380 shs
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$17.65
+0.5%
$17.53
$6.08
$45.08
$691.44M1.48793,110 shs621,585 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Embecta Corp. stock logo
EMBC
Embecta
+0.09%+6.35%-13.09%-35.64%-60.64%
Paragon 28, Inc. stock logo
FNA
Paragon 28
-3.98%-0.82%+2.88%-21.29%-46.24%
Nevro Corp. stock logo
NVRO
Nevro
-2.19%+1.95%-8.21%-30.66%-61.71%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-0.57%+0.63%-4.67%+15.52%-60.51%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Embecta Corp. stock logo
EMBC
Embecta
3.9291 of 5 stars
2.84.03.30.01.83.31.9
Paragon 28, Inc. stock logo
FNA
Paragon 28
1.7191 of 5 stars
3.51.00.00.00.04.20.6
Nevro Corp. stock logo
NVRO
Nevro
1.7194 of 5 stars
4.02.00.00.00.01.70.6
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
3.269 of 5 stars
3.11.00.04.31.31.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Embecta Corp. stock logo
EMBC
Embecta
1.50
Reduce$16.0053.85% Upside
Paragon 28, Inc. stock logo
FNA
Paragon 28
3.00
Buy$17.6796.95% Upside
Nevro Corp. stock logo
NVRO
Nevro
2.00
Hold$21.2382.87% Upside
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
2.18
Hold$22.1825.68% Upside

Current Analyst Ratings

Latest SILK, EMBC, NVRO, and FNA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Nevro Corp. stock logo
NVRO
Nevro
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$18.00 ➝ $16.00
4/11/2024
Nevro Corp. stock logo
NVRO
Nevro
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$20.00 ➝ $16.00
4/8/2024
Nevro Corp. stock logo
NVRO
Nevro
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $14.00
4/5/2024
Paragon 28, Inc. stock logo
FNA
Paragon 28
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$18.00
4/4/2024
Paragon 28, Inc. stock logo
FNA
Paragon 28
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$17.00
4/3/2024
Nevro Corp. stock logo
NVRO
Nevro
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.00 ➝ $16.00
3/28/2024
Paragon 28, Inc. stock logo
FNA
Paragon 28
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$17.00
3/27/2024
Paragon 28, Inc. stock logo
FNA
Paragon 28
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$18.00
3/7/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$24.00
3/1/2024
Paragon 28, Inc. stock logo
FNA
Paragon 28
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$16.00 ➝ $17.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $23.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Embecta Corp. stock logo
EMBC
Embecta
$1.12B0.53$3.53 per share2.95($14.34) per share-0.73
Paragon 28, Inc. stock logo
FNA
Paragon 28
$216.39M3.44N/AN/A$2.15 per share4.17
Nevro Corp. stock logo
NVRO
Nevro
$425.17M1.00N/AN/A$8.10 per share1.43
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$177.13M3.90N/AN/A$3.88 per share4.55

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Embecta Corp. stock logo
EMBC
Embecta
$70.40M$0.9510.954.71N/A4.93%-18.66%12.38%5/9/2024 (Confirmed)
Paragon 28, Inc. stock logo
FNA
Paragon 28
-$47.84M-$0.58N/AN/AN/A-22.11%-22.51%-13.98%5/2/2024 (Estimated)
Nevro Corp. stock logo
NVRO
Nevro
-$92.21M-$2.57N/AN/AN/A-21.69%-30.22%-15.17%5/7/2024 (Confirmed)
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$55.74M-$1.44N/AN/AN/A-31.70%-36.38%-21.41%4/30/2024 (Confirmed)

Latest SILK, EMBC, NVRO, and FNA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Embecta Corp. stock logo
EMBC
Embecta
$0.43N/A-$0.43N/AN/AN/A  
5/7/2024N/A
Nevro Corp. stock logo
NVRO
Nevro
-$1.02N/A+$1.02N/AN/AN/A  
4/30/2024N/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$0.40N/A+$0.40N/AN/AN/A  
2/29/2024Q4 2023
Paragon 28, Inc. stock logo
FNA
Paragon 28
-$0.10-$0.19-$0.09-$0.14$60.73 million$60.56 million
2/28/2024Q4 2023
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$0.40-$0.33+$0.07-$0.33$42.23 million$47.27 million    
2/21/2024Q4 2023
Nevro Corp. stock logo
NVRO
Nevro
-$0.50-$0.15+$0.35-$0.05$115.93 million$116.18 million
2/9/202412/31/2023
Embecta Corp. stock logo
EMBC
Embecta
$0.46$0.61+$0.15$0.85$264.92 million$277.30 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Embecta Corp. stock logo
EMBC
Embecta
$0.605.77%N/A63.16%N/A
Paragon 28, Inc. stock logo
FNA
Paragon 28
N/AN/AN/AN/AN/A
Nevro Corp. stock logo
NVRO
Nevro
N/AN/AN/AN/AN/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/AN/AN/AN/AN/A

Latest SILK, EMBC, NVRO, and FNA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/9/2024
Embecta Corp. stock logo
EMBC
Embecta
Quarterly$0.153.69%2/27/20242/28/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Embecta Corp. stock logo
EMBC
Embecta
N/A
2.20
1.75
Paragon 28, Inc. stock logo
FNA
Paragon 28
0.62
4.21
2.30
Nevro Corp. stock logo
NVRO
Nevro
0.72
6.37
4.94
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
0.50
7.95
6.97

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Embecta Corp. stock logo
EMBC
Embecta
93.83%
Paragon 28, Inc. stock logo
FNA
Paragon 28
63.57%
Nevro Corp. stock logo
NVRO
Nevro
95.52%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/A

Insider Ownership

CompanyInsider Ownership
Embecta Corp. stock logo
EMBC
Embecta
0.28%
Paragon 28, Inc. stock logo
FNA
Paragon 28
15.32%
Nevro Corp. stock logo
NVRO
Nevro
3.20%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
6.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Embecta Corp. stock logo
EMBC
Embecta
2,20057.58 million57.42 millionOptionable
Paragon 28, Inc. stock logo
FNA
Paragon 28
57482.91 million70.21 millionOptionable
Nevro Corp. stock logo
NVRO
Nevro
1,21536.68 million35.51 millionOptionable
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
47439.18 million36.55 millionOptionable

SILK, EMBC, NVRO, and FNA Headlines

SourceHeadline
Silk Road Medical to Present at the BofA Securities 2024 Healthcare ConferenceSilk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
globenewswire.com - April 23 at 4:30 PM
All You Need to Know About Silk Road Medical (SILK) Rating Upgrade to BuyAll You Need to Know About Silk Road Medical (SILK) Rating Upgrade to Buy
zacks.com - April 23 at 1:00 PM
Silk Road Medical (SILK) to Release Quarterly Earnings on TuesdaySilk Road Medical (SILK) to Release Quarterly Earnings on Tuesday
americanbankingnews.com - April 23 at 4:32 AM
Silk Road Medical (SILK) to Release Earnings on TuesdaySilk Road Medical (SILK) to Release Earnings on Tuesday
marketbeat.com - April 23 at 4:30 AM
The Silk Road of the SeaThe Silk Road of the Sea
sundaytimes.lk - April 22 at 3:28 PM
Heard of Zoroastrianism in history class? The ancient religion still has fervent followers.Heard of Zoroastrianism in history class? The ancient religion still has fervent followers.
nationalgeographic.com - April 22 at 3:28 PM
Peregrine Capital Management LLC Sells 338,639 Shares of Silk Road Medical, Inc (NASDAQ:SILK)Peregrine Capital Management LLC Sells 338,639 Shares of Silk Road Medical, Inc (NASDAQ:SILK)
marketbeat.com - April 12 at 6:44 AM
Silk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Rating of "Hold" from BrokeragesSilk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Rating of "Hold" from Brokerages
marketbeat.com - April 12 at 2:17 AM
Silk Road Medical (NASDAQ:SILK) Stock Price Up 3.5%Silk Road Medical (NASDAQ:SILK) Stock Price Up 3.5%
marketbeat.com - April 11 at 12:45 PM
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
globenewswire.com - April 9 at 4:30 PM
Silk Road Medicals (SILK) New Launch to Aid Its TCAR PortfolioSilk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio
zacks.com - April 8 at 11:25 AM
China, Sri Lanka forging stronger bondsChina, Sri Lanka forging stronger bonds
chinadaily.com.cn - April 7 at 3:48 PM
Silk Road Medical (NASDAQ:SILK) Trading Up 5.1%Silk Road Medical (NASDAQ:SILK) Trading Up 5.1%
marketbeat.com - April 5 at 3:45 PM
Taiwan Earthquake: What to Know About Travel and How to HelpTaiwan Earthquake: What to Know About Travel and How to Help
msn.com - April 5 at 1:08 AM
The One and Only Benedict WongThe One and Only Benedict Wong
vulture.com - April 4 at 7:57 AM
Silk Road Medical Launches Enroute Transcarotid NPS PlusSilk Road Medical Launches Enroute Transcarotid NPS Plus
evtoday.com - April 4 at 7:57 AM
Worker injured by electric shock from power line in BiddefordWorker injured by electric shock from power line in Biddeford
finance.yahoo.com - April 3 at 11:54 AM
Silk Road launches next-gen transcarotid neuroprotection systemSilk Road launches next-gen transcarotid neuroprotection system
massdevice.com - April 3 at 11:54 AM
Ancient People Also Had Sunburns, So They Used These 4 Forms of ProtectionAncient People Also Had Sunburns, So They Used These 4 Forms of Protection
msn.com - April 3 at 6:53 AM
Traditional Chinese medicine gains wider recognition around worldTraditional Chinese medicine gains wider recognition around world
sb.by - April 3 at 6:53 AM
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUSSilk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
globenewswire.com - April 2 at 4:30 PM
Turkmenistan to launch traffic on Tejen - Mary expresswayTurkmenistan to launch traffic on Tejen - Mary expressway
en.trend.az - March 30 at 2:13 PM
Number of Russian Crocus City Hall terrorist attack victims increasesNumber of Russian Crocus City Hall terrorist attack victims increases
en.trend.az - March 30 at 2:13 PM
Rep. Barbara Lee Doubles Down On Opposing Military Budget: Black People Need A Global PerspectiveRep. Barbara Lee Doubles Down On Opposing Military Budget: Black People Need 'A Global Perspective'
theroot.com - March 29 at 2:31 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Embecta logo

Embecta

NASDAQ:EMBC
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Paragon 28 logo

Paragon 28

NYSE:FNA
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
Nevro logo

Nevro

NYSE:NVRO
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.
Silk Road Medical logo

Silk Road Medical

NASDAQ:SILK
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.